Munich, Germany

Reiner Lammers


Average Co-Inventor Count = 8.8

ph-index = 6

Forward Citations = 221(Granted Patents)


Location History:

  • Munich, DE (1997 - 1999)
  • Munchen, DE (1997 - 2001)

Company Filing History:


Years Active: 1997-2001

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Reiner Lammers: Innovator in Platelet Derived Growth Factor Research

Introduction

Reiner Lammers is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biomedical research, particularly in the treatment of disorders related to platelet derived growth factor (PDGF). With a total of 7 patents, his work has the potential to impact the treatment of various cancers and cell proliferative disorders.

Latest Patents

Lammers' latest patents focus on compounds that inhibit PDGF receptor (PDGF-R) activity. These compounds are designed to selectively target members of the PDGF-R super family, which includes PDGF-R and related kinases such as Flt and KDR. The featured compounds have shown effectiveness in cell cultures, reducing PDGF-R activity and potentially inhibiting tumor cell growth in vivo. His research aims to provide new treatment options for patients suffering from disorders characterized by inappropriate PDGF-R activity.

Career Highlights

Throughout his career, Reiner Lammers has worked with prominent organizations, including Sugen Incorporated and the Max Planck Society for the Advancement of Science. His innovative research has positioned him as a key figure in the field of cancer treatment and regenerative medicine.

Collaborations

Lammers has collaborated with esteemed colleagues such as Axel Ullrich and Klaus Peter Hirth. These partnerships have furthered his research and contributed to the development of effective therapeutic strategies.

Conclusion

Reiner Lammers is a distinguished inventor whose work in platelet derived growth factor research has the potential to transform cancer treatment. His innovative compounds and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…